The Government plans to move public health research work from its existing ageing facilities at Porton Down to Harlow

The £400m project will involve redeveloping the vacant GlaxoSmithKline site at the New Frontiers Science Park to create a centre of excellence for research, health improvement and protection.

The proposals include keeping existing buildings and developing new research facilities and offices within a campus setting.

PHE plans to reuse and refurbish four of the existing buildings created by GSK. This will provide up to 64,000 sq m of floor space in the retained buildings.

Several other buildings and structures will have to be demolished to make way for the proposed development.

The world-class science research facilities will bring together world renowned scientists to work in a single integrated campus.

Contractors are being invited to a bidders days on 7 September to hear more details about the four contract lots planned to deliver the ambitious scheme.

Bidders interested in completing a PQQ submission and attending the PQQ Industry Day are required to access and return a completed confidential disclosure agreement because of the sensitive nature of the project. Further information is available from the web portal.